RNXT · NASDAQ
RenovoRx (RNXT) Stock Price & Fundamentals
RenovoRx (RNXT) closed at $476.66 on Oct 9, 2026, up 1.46% from the previous close of $469.80.
Share price, past year
1Y +10.42%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $476.66 |
| Sep 30, 2026 | $460.27 |
| Aug 31, 2026 | $469.28 |
| Jul 31, 2026 | $460.13 |
| Jun 30, 2026 | $453.94 |
| May 29, 2026 | $436.87 |
| Apr 30, 2026 | $421.77 |
| Mar 31, 2026 | $424.65 |
| Feb 27, 2026 | $413.58 |
| Jan 30, 2026 | $396.58 |
| Dec 31, 2025 | $389.69 |
| Nov 28, 2025 | $398.72 |
| Oct 31, 2025 | $401.44 |
Key statistics
- Market cap
- $21.51B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.31
- Revenue (TTM)
- $1.98M
- Net income (TTM)
- −$12.29M
- Shares outstanding
- 45.1M
- Dividend yield
- —
- 52-week range
- $382.69 – $476.66
RenovoRx's market cap is $21.51B, based on a share price of $476.66 and 45.1M shares outstanding as of Jun 30, 2026.
Financials
RenovoRx reported revenue of $1.12M for fiscal 2025, up 2,511.63% from fiscal 2024.
RenovoRx reported a net loss of $11.17M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.12M | +2,511.6% | −$11.17M | −994.5% | −$0.32 | −$10.98M |
| FY2024ended Dec 31, 2024 | $43.00K | — | −$8.81M | −20,497.7% | −$0.40 | −$9.14M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $909.00K | −$2.91M | −$0.06 |
| Q1 FY2026ended Mar 31, 2026 | $563.00K | −$3.52M | −$0.09 |
| Q4 FY2025ended Dec 31, 2025 | $238.00K | −$2.94M | −$0.08 |
| Q3 FY2025ended Sep 30, 2025 | $266.00K | −$2.91M | −$0.08 |
| Q2 FY2025ended Jun 30, 2025 | $422.00K | −$2.90M | −$0.08 |
| Q1 FY2025ended Mar 31, 2025 | $197.00K | −$2.42M | −$0.08 |
Company profile
- Name
- RenovoRx, Inc.
- Ticker
- RNXT
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 2570 W. El Camino Real, Ste. 320,, Mountain View, CA 94040
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001574094
Recent SEC filings
- Aug 20, 2026
- Aug 13, 2026
- Aug 12, 2026
- Aug 4, 2026
- Jul 2, 2026
- Jun 30, 2026
- May 15, 2026
- May 14, 2026
Frequently asked questions
What is RenovoRx's stock price?
RenovoRx (RNXT) closed at $476.66 on Oct 9, 2026, up 1.46% from the previous close of $469.80.
What is RenovoRx's market cap?
RenovoRx's market cap is $21.51B, based on a share price of $476.66 and 45.1M shares outstanding as of Jun 30, 2026.
How much revenue does RenovoRx make?
RenovoRx reported revenue of $1.12M for fiscal 2025, up 2,511.63% from fiscal 2024.
Does RenovoRx pay a dividend?
RenovoRx's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from RenovoRx, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures